SCHEMBL4924045

SCHEMBL4924045

O=C(NO)c1ccccc1C(=O)Nc1cc2ccccc2cc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
GAA P10253 3/20 0.53
MPO P05164 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HIF1A Q16665 1/20 0.53
H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.49
EP300 Q09472 1/20 0.49
PRMT1 Q99873 1/20 0.49
NPC1 O15118 7/20 0.49
RAB9A P51151 5/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 2/20 0.49
TP53 P04637 1/20 0.49
MMP3 P08254 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
MAPT P10636 3/20 0.48
MAPK1 P28482 1/20 0.48
NOD2 Q9HC29 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925929 0.92 GAA (0.52) KDM4EGAAMPOSMN1; SMN2HIF1A
SCHEMBL4915600 0.91 H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 (0.48) KDM4EGAAMPOSMN1; SMN2HIF1A
SCHEMBL4930820 0.80 NPC1 (0.76) KDM4EGAAMPOSMN1; SMN2HIF1A
SCHEMBL31354441 0.79 MEN1 (0.70) KDM4EGAAMPOSMN1; SMN2HIF1A
SCHEMBL10724443 0.79 MEN1 (0.70) KDM4EGAAMPOSMN1; SMN2HIF1A
SCHEMBL12368153 0.79 KCNMA1 (0.71) KDM4EGAASMN1; SMN2HIF1ANPC1
SCHEMBL4928655 0.78 KCNMA1 (0.70) KDM4EGAASMN1; SMN2HIF1ANPC1
Potassium SCHEMBL32681949 0.78 MEN1 (0.68) KDM4EGAAMPOSMN1; SMN2HIF1A
SCHEMBL5159074 0.76 MEN1 (0.66) KDM4EGAANPC1RAB9AMEN1
SCHEMBL31330826 0.76 MEN1 (0.66) KDM4EGAAMPOSMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 KDM4E 1359/4885GAA 1690/4885MPO 34/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 KDM4E 1265/4885GAA 1635/4885MPO 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.